# Descartes-08 for Patients With Systemic Lupus Erythematosus

> **NCT06038474** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Cartesian Therapeutics** · enrollment: 6 (actual)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **DRUG:** Descartes-08

## Key facts

- **NCT ID:** NCT06038474
- **Lead sponsor:** Cartesian Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-12
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06038474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06038474, "Descartes-08 for Patients With Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06038474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*